Synopsis of recent research by authors named "Ana Maria Hurtado"
- Ana Maria Hurtado's recent research focuses on the intersection of cancer treatment and immunology, particularly the role of various therapeutic agents, including tricyclic antidepressants and immune cell subsets, in modifying treatment responses and outcomes in cancer patients.
- In the clinical trial HITCLIF, Hurtado explores the effects of imipramine on cancer patients with elevated Fascin1 levels, highlighting the significance of understanding cytoskeletal restructuring in tumor invasion and metastasis.
- Hurtado also investigates the implications of chronic graft-versus-host disease in myelodysplastic syndromes, suggesting it may mitigate the adverse impact of somatic mutations in patients undergoing hematopoietic stem cell transplantation.